Kim Kelderman
Director. Files against 2 companies. Everything below is filed with the SEC within two business days of the trade. Filed as Kelderman Kim.
Where they file
Someone who files against several companies usually sits on their boards.
Every reported line
Purchases, sales, grants, option exercises and shares withheld for tax.
| Company | Action | Value |
|---|---|---|
| CNMDConmed Corp2026-09-08 | Option exercise | — |
| CNMDConmed Corp2026-09-08 | Option exercisederivative | — |
| TECHBio-Techne Corp2026-08-17 | Grantderivative | — |
| TECHBio-Techne Corp2026-08-17 | Grantderivative | — |
| TECHBio-Techne Corp2026-08-15 | Option exercise | — |
| TECHBio-Techne Corp2026-08-15 | Withheld for tax | $783.4K |
| TECHBio-Techne Corp2026-08-15 | Option exercisederivative | — |
| TECHBio-Techne Corp2026-08-15 | Sale to issuerderivative | — |
| TECHBio-Techne Corp2026-08-15 | Sale to issuerderivative | — |
| TECHBio-Techne Corp2026-08-15 | Option exercisederivative | — |
| TECHBio-Techne Corp2026-08-15 | Sale to issuerderivative | — |
| TECHBio-Techne Corp2026-08-15 | Sale to issuerderivative | — |
| TECHBio-Techne Corp2026-08-15 | Option exercisederivative | — |
| TECHBio-Techne Corp2026-08-15 | Option exercisederivative | — |
| TECHBio-Techne Corp2026-07-28 | Option exercise | $1.7M |
| TECHBio-Techne Corp2026-07-28 | Withheld for tax | $2.1M |
| TECHBio-Techne Corp2026-07-28 | Option exercisederivative | — |
Source: SEC Form 4 and Form 144 filings, via EDGAR. Form 144 carries no filer identifier, so those notices are matched to this page by name alone. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
Follow Kim Kelderman by email
Kim Kelderman's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.